Related Experiment Videos
Vitamin E mediated response of smooth muscle cell to oxidant stress
A Azzi1, D Boscoboinik, S Clément
1Institut für Biochemie und Molekularbiologie, Universität Bern, Switzerland. angelo.azzi@mci.unibe.ch
Abstract:
Oxidant stress is associated with diminution of antioxidant molecules, such as alpha-tocopherol. Alpha-tocopherol specifically decreases, in a concentration dependent way, the proliferation of vascular smooth muscle cells. At the same concentrations (10-50 microM) it induces inhibition of protein kinase C (PKC) activity. The latter event is not due to a decrease in PKC level or to alpha-tocopherol binding to PKC, but it results from increase of protein phosphatase 2A1 activity. In vitro data, as well as at a cellular level, demonstrates that protein phosphatase 2A1 is activated, in its trimeric structure--but not as a dimer by alpha-tocopherol. This activation is followed by PKC-alpha dephosphorylation. The activation of protein phosphatase 2A1 and deactivation of PKC-alpha affect the AP1 transcription factor, resulting in a change in the composition and the binding of this factor to DNA. By transfecting smooth muscle cell with a construct containing three TRE (TPA responsive elements), the promoter thymidine kinase and the reporter gene chloramphenicol-acetyl-transferase a modulation of gene expression by alpha-tocopherol is observed. Beta-tocopherol does not cause any of the responses observed with alpha-tocopherol and R,R,R-alpha-tocopherol is twice as potent as all-rac-alpha-tocopherol. When added together, beta-tocopherol prevents the effects of alpha-tocopherol indicating that the mechanism involved is not related to the radical-scavenging properties of these two molecules, which are essentially equal. By differential display analysis it has been found that several genes of smooth muscle cells are differentially transcribed in the presence of alpha-tocopherol but not beta-tocopherol. In particular, the gene of alpha-tropomyosin shows a transient enhancement of transcription as a function of the cell cycle time. Alpha-tropomyosin translation is also increased by alpha-tocopherol and not by beta-tocopherol. Because no changes of mRNA stability can be observed in the presence of alpha-tocopherol, the data supports the conclusion of a transcriptional control exerted by alpha-tocopherol on alpha-tropomyosin. Generally, the data strongly suggests the existence of a ligand/receptor type of mechanism at the basis of alpha-tocopherol action. It is concluded that an oxidative stress-induced diminution of alpha-tocopherol in smooth muscle cell activates a reaction cascade leading to changes in gene expression and increase in cell proliferation by a non-antioxidant mechanism.
Insights
Oxidative stress reduces alpha-tocopherol, impacting vascular smooth muscle cell proliferation via a non-antioxidant pathway. Alpha-tocopherol activates protein phosphatase 2A1, deactivating protein kinase C and altering gene expression, notably alpha-tropomyosin.
Area of Science:
- Biochemistry and Molecular Biology
- Cell Biology
- Vascular Biology
Background:
- Oxidative stress is linked to reduced antioxidant levels like alpha-tocopherol.
- Alpha-tocopherol influences vascular smooth muscle cell (VSMC) proliferation and protein kinase C (PKC) activity.
- The precise non-antioxidant mechanisms of alpha-tocopherol in VSMCs require elucidation.
Purpose of the Study:
- To investigate the non-antioxidant mechanisms by which alpha-tocopherol affects VSMC proliferation.
- To identify the molecular targets and signaling pathways involved in alpha-tocopherol's action.
- To compare the effects of alpha-tocopherol with beta-tocopherol and stereoisomers.
Main Methods:
- In vitro and cellular assays to assess VSMC proliferation, PKC activity, and protein phosphatase 2A1 (PP2A1) activity.
- Analysis of protein dephosphorylation and transcription factor AP1 binding.
- Gene expression analysis using differential display and reporter gene constructs (luciferase assay).
Main Results:
- Alpha-tocopherol inhibits VSMC proliferation and PKC activity in a concentration-dependent manner.
- This inhibition is mediated by the activation of trimeric PP2A1, leading to PKC-alpha dephosphorylation.
- Alpha-tocopherol modulates AP1 transcription factor activity and differentially affects gene transcription, including a transient enhancement of alpha-tropomyosin.
- Beta-tocopherol does not elicit these effects, and it can prevent alpha-tocopherol's actions, suggesting a non-antioxidant mechanism.
Conclusions:
- Alpha-tocopherol exerts non-antioxidant effects on VSMCs through a ligand/receptor-like mechanism.
- Activation of PP2A1 and subsequent modulation of gene expression, particularly alpha-tropomyosin, are key to its action.
- These findings highlight a novel signaling pathway for alpha-tocopherol in vascular health, distinct from its antioxidant properties.